Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis

Filip Stanicic, Vladimir Zah, Dimitrije Grbic, Djurdja Vukicevic

Open source

DOI
10.5055/jom.0929
Published
2025-11-01
Container
Journal of Opioid Management
Publisher
Weston Medical Publishing
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5055/jom.0929,
  title = {Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis},
  author = {Filip Stanicic and Vladimir Zah and Dimitrije Grbic and Djurdja Vukicevic},
  year = {2025},
  journal = {Journal of Opioid Management},
  doi = {10.5055/jom.0929},
  url = {https://doi.org/10.5055/jom.0929}
}

RIS

TY  - JOUR
TI  - Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis
AU  - Filip Stanicic
AU  - Vladimir Zah
AU  - Dimitrije Grbic
AU  - Djurdja Vukicevic
PY  - 2025
JO  - Journal of Opioid Management
DO  - 10.5055/jom.0929
UR  - https://doi.org/10.5055/jom.0929
ER  - 

APA

Stanicic, F., Zah, V., Grbic, D., & Vukicevic, D. (2025). Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis. Journal of Opioid Management. https://doi.org/10.5055/jom.0929

Source records